Isoproterenol tilt-table testing in patients with syncope and structural heart disease

R Sheldon; S Rose; M L Koshman

doi:10.1016/s0002-9149(96)00403-1

Isoproterenol tilt-table testing in patients with syncope and structural heart disease

Am J Cardiol. 1996 Sep 15;78(6):700-3. doi: 10.1016/s0002-9149(96)00403-1.

Authors

R Sheldon¹, S Rose, M L Koshman

Affiliation

¹ Cardiovascular Research Group, University of Calgary, Alberta, Canada.

PMID: 8831414
DOI: 10.1016/s0002-9149(96)00403-1

Abstract

We studied 55 patients with syncope and structural heart disease using both tilt-table testing and electrophysiologic studies. Although sustained ventricular tachycardia was found in 21 of 55 patients (38%), and neuromediated syncope in 18 of 51 patients (35%), only 16% of patients with ventricular tachycardia had a positive tilt-table test.

Publication types

Comparative Study
Research Support, Non-U.S. Gov't

MeSH terms

Adrenergic beta-Agonists*
Aged
Female
Heart Diseases / physiopathology*
Hemodynamics
Humans
Isoproterenol*
Male
Middle Aged
Sensitivity and Specificity
Syncope / physiopathology*
Tilt-Table Test / adverse effects
Tilt-Table Test / methods*

Substances

Adrenergic beta-Agonists
Isoproterenol